547 related articles for article (PubMed ID: 9815573)
1. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
2. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
[TBL] [Abstract][Full Text] [Related]
4. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
5. High telomerase activity is associated with cell cycle deregulation and rapid progression in endometrioid adenocarcinoma of the uterus.
Bonatz G; Frahm SO; Klapper W; Helfenstein A; Heidorn K; Jonat W; Krupp G; Parwaresch R; Rudolph P
Hum Pathol; 2001 Jun; 32(6):605-14. PubMed ID: 11431715
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN).
Koeneman KS; Pan CX; Jin JK; Pyle JM; Flanigan RC; Shankey TV; Diaz MO
J Urol; 1998 Oct; 160(4):1533-9. PubMed ID: 9751408
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
8. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
9. Determination of telomerase activity and telomere length.
Wu KD; Moore MA
Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity could be used as a marker for neoplastic transformation in gastric adenocarcinoma: but it does not have a prognostic significance.
Gümüş-Akay G; Unal AE; Bayar S; Karadayi K; Elhan AH; Sunguroĝlu A; Tükün A
Genet Mol Res; 2007 Feb; 6(1):41-9. PubMed ID: 17469053
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in cell lines of pediatric soft tissue sarcomas.
Kleideiter E; Schwab M; Friedrich U; Koscielniak E; Schafer BW; Klotz U
Pediatr Res; 2003 Nov; 54(5):718-23. PubMed ID: 12904596
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
Katayama S; Shiota G; Kawasaki H
Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
[TBL] [Abstract][Full Text] [Related]
13. Clinical usefulness of telomerase activation and telomere length in head and neck cancer.
Patel MM; Parekh LJ; Jha FP; Sainger RN; Patel JB; Patel DD; Shah PM; Patel PS
Head Neck; 2002 Dec; 24(12):1060-7. PubMed ID: 12454944
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in giant cell tumors of bone.
Matsuo T; Hiyama E; Sugita T; Shimose S; Kubo T; Mochizuki Y; Adachi N; Kojima K; Sharman P; Ochi M
Ann Surg Oncol; 2007 Oct; 14(10):2896-902. PubMed ID: 17653593
[TBL] [Abstract][Full Text] [Related]
15. Analysis of telomerase activity and telomere length in bone and soft tissue tumors.
Terasaki T; Kyo S; Takakura M; Maida Y; Tsuchiya H; Tomita K; Inoue M
Oncol Rep; 2004 Jun; 11(6):1307-11. PubMed ID: 15138570
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in primary prostate cancer.
Lin Y; Uemura H; Fujinami K; Hosaka M; Harada M; Kubota Y
J Urol; 1997 Mar; 157(3):1161-5. PubMed ID: 9072562
[TBL] [Abstract][Full Text] [Related]
17. Correlation between telomerase expression and terminal restriction fragment length ratio in non-small cell lung cancer--an adjusted measurement and its clinical significance.
Hsu CP; Miaw J; Shai SE; Chen CY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):425-31. PubMed ID: 15296909
[TBL] [Abstract][Full Text] [Related]
18. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
Tahara H; Yasui W; Tahara E; Fujimoto J; Ito K; Tamai K; Nakayama J; Ishikawa F; Tahara E; Ide T
Oncogene; 1999 Feb; 18(8):1561-7. PubMed ID: 10102626
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity: a prevalent marker of malignant human prostate tissue.
Sommerfeld HJ; Meeker AK; Piatyszek MA; Bova GS; Shay JW; Coffey DS
Cancer Res; 1996 Jan; 56(1):218-22. PubMed ID: 8548767
[TBL] [Abstract][Full Text] [Related]
20. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
